4D Molecular Therapeutics FDMT
NASDAQ FDMT
$14.31 -0.18 (-1.24%)
As of: Sep 30, 2026 · 3:59 PM EDT

4D Molecular Therapeutics (FDMT) Change in Receivables (2020 - 2022)

Updated

4D Molecular Therapeutics (FDMT) recorded Change in Receivables of -$47,000 in FY2022, compared with -$1.44 million in FY2021.

Analysis

4D Molecular Therapeutics (FDMT) Change in Receivables (2020 - 2022) Analysis & Trends

Starting with FY2019, 4D Molecular Therapeutics' Change in Receivables history includes 4 years.

  • Annual Change in Receivables has ranged from -$1.44 million in FY2021 to $508,000 in FY2020 over the past five years.
  • Per Business Quant data, FDMT's Change in Receivables was -$1.44 million in FY2021, $508,000 in FY2020 and -$146,000 in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 1.35 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 1.37 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn -
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 1.09 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 333.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 140.20 Mn
10 4D Molecular Therapeutics 1.02 Bn -441.70 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 -47,000.00
Dec 31, 2021 -744,000.00
Sep 30, 2021 -427,000.00
Jun 30, 2021 253,000.00
Mar 31, 2021 -521,000.00
Dec 31, 2020 590,000.00
Sep 30, 2020 168,000.00
Jun 30, 2020 -151,000.00
Mar 31, 2020 -99,000.00
API Access

4D Molecular Therapeutics Change in Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-receivables&ticker=FDMT&period=max&api_key=YOUR_API_KEY